REQUEST A DEMO
Total
USD $0.00
Search more companies

Pannonpharma Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Electronic Shopping and Mail-Order Houses | Real Estate
Full name: PANNONPHARMA Gyogyszergyarto Kft. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

pannonpharma is a pharmaceutical company that specializes in the development and production of antiviral and gastrointestinal medications. It is a recognized player in the Hungarian pharmaceutical industry and is a member of the Hungarian Biotechnology Association. The company offers a range of products for the treatment of cardiovascular diseases and nerve-based circulatory complaints, as well as antiviral medications for gastrointestinal disinfection in COVID-19 patients. pannonpharma is also involved in pharmaceutical research and development, with a focus on utilizing the potential of plants and herbs.

Headquarters
Pannonpharma ut 1.
Pecsvarad; Baranya; Postal Code: 7720

Contact Details: Purchase the Pannonpharma Kft. report to view the information.

Website: http://www.pannonpharma.hu

Basic Information
Total Employees:
Purchase the Pannonpharma Kft. report to view the information.
Outstanding Shares:
Purchase the Pannonpharma Kft. report to view the information.
Registered Capital:
Purchase the Pannonpharma Kft. report to view the information.
Financial Auditors:
Purchase the Pannonpharma Kft. report to view the information.
Incorporation Date:
May 16, 1994
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Biotechnologiai Innovacios Bazis Kft.
CLONGEN GYOGYSZERKERESKEDELMI Kft.
Centipede Labs Kft.
Company Performance
Financial values in the chart are available after Pannonpharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.49%
Total operating revenue
0.72%
Operating profit (EBIT)
59.8%
EBITDA
22.96%
Net Profit (Loss) for the Period
64.46%
Total assets
0.71%
Total equity
9.19%
Operating Profit Margin (ROS)
3.14%
Net Profit Margin
3%
Return on Equity (ROE)
2.83%
Debt to Equity Ratio
-2.82%
Quick Ratio
0.2%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?